Inactive

Background The U.S. Food and Drug Administration – Office of Criminal Investigations (FDA-OCI) protects the public health and furthers the FDA mission by investigating alleged criminal violations of t... Background The U.S. Food and Drug Administration – Office of Criminal Investigations (FDA-OCI) protects the public health and furthers the FDA mission by investigating alleged criminal violations of the Federal Food, Drug, and Cosmetic Act (FDCA) and other related statutes. FDA-OCI concentrates its resources on investigations that pose a significant danger to public health. The Seized Computer Evidence Recovery Specialists (SCERS) who work for FDA/OCI are responsible for imaging and processing computers, cell phones, tablets, and other electronic media that is encountered and/or recovered during the course of investigations for use in court. In order to analyze many image sets, forensic software and hardware that is capable of parsing out many types of mobile device operating systems are necessary for conducting examinations. One such operating system is iOS. The GrayKey is a hardware unit that allows for access to the iOS devices while maintaining the chain of custody in order to extract and analyze evidentiary data once lawful access is established. This requirement supports the effort by the OCI to be able to continue accessing data from iOS devices acquired during the course of investigations. Objective The objective of this contract is to provide continued maintenance for three (3) existing GrayKey licenses. This requirement will allow investigators to access data found on iOS devices for use in investigations. Instructions to Quoters This solicitation is issued under FAR Part 12 and 13.5 procedures. This is an unrestricted procurement. The NAICS code is 541519. The small business size standard is $30 million. Quoters shall certify their quotes to be valid for 30 days. Quoters shall be Original Equipment Manufacturers, authorized resellers and/or servicing agents of the software manufacturer. Quoters should ensure that all information is provided to determine technical acceptability and that their initial submission represents their best pricing. The Government will not research items to determine compatibility; all information regarding compatibility must be contained within the quotation. Quotations must meet all the requirements of this solicitation in order to be considered technically acceptable. Quoters shall submit all assumptions in their quotation. All Quoters providing quotations must clearly state the overall cost to the Government. Quoters shall submit a complete pricing for all products listed in this RFQ. Partial quotes will not be considered. Incomplete pricing or pricing with omissions may not be considered for award. Please submit questions to Min Jie (Terry) Zeng via email at minjie.zeng@fda.hhs.gov by May 20, 2020, 3PM Eastern Time. Please submit quotes to Min Jie (Terry) Zeng via email at minjie.zeng@fda.hhs.gov by May 23, 2020, 12PM Eastern Time. Evaluation Criteria The Government shall award a contract resulting from this solicitation to the responsible quoter as a fixed?price contract on the lowest price technically acceptable (LPTA) evaluation method. Award will be made on the basis of the lowest evaluated price meeting or exceeding the non?cost factor (technical conformance to the requirements of the solicitation). The Quoter’s initial quotation should contain the Quoter’s best terms from a price standpoint. Failure to demonstrate meeting any of the requirements will result in a rating of technically unacceptable and will not be considered for award.